Clinical trials
Recruiting Phase 2 Nervous System Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2023 | 2 |
| 2025 | 4 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| MapLight Therapeutics | 2 |
| Alberto Esquenazi | 1 |
| Eli Lilly and Company | 1 |
| GenSight Biologics | 1 |
| GlaxoSmithKline | 1 |
| Military Institute od Medicine National Research Institute | 1 |
| North Florida Foundation for Research and Education | 1 |
| PepGen Inc | 1 |
| Seattle Children's Hospital | 1 |
| University of Virginia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nervous System Diseases | 12 |
| Brain Diseases | 5 |
| Central Nervous System Diseases | 5 |
| Alzheimer Disease | 4 |
| Neurodegenerative Diseases | 4 |
| Mental Disorders | 3 |
| Cognitive Dysfunction | 2 |
| Dementia | 2 |
| Genetic Diseases, Inborn | 2 |
| Neurocognitive Disorders | 2 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.